HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
9.05
-0.20 (-2.16%)
Jul 29, 2026, 3:00 PM CST

SHA:600829 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
136.46133.84213.27292.16264.48277.3
Depreciation & Amortization
57.4257.4261.5460.1863.9960.44
Other Amortization
5.625.623.535.924.54.33
Loss (Gain) From Sale of Assets
0.440.44-0.230.350.36-0.07
Asset Writedown & Restructuring Costs
2.262.262.150.810.31.95
Loss (Gain) From Sale of Investments
---13.9-3.89--
Provision & Write-off of Bad Debts
59.9759.9719.2424.85-11.089.17
Other Operating Activities
-14.7624.2228.2227.0227.0117.82
Change in Accounts Receivable
163.19163.19-10.6-228.880.7-292.96
Change in Inventory
-129.47-129.4716.45-41.4131.2217.35
Change in Accounts Payable
-1.15-1.15-204.15201.01-76.03-326.39
Operating Cash Flow
263.61299.98115.44332.99307.33-233
Operating Cash Flow Growth
76.91%159.86%-65.33%8.35%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-17.74-17.16-8.04-23.48-6.42-12.24
Sale of Property, Plant & Equipment
0.10.130.150.260.550.69
Other Investing Activities
----156.64--
Investing Cash Flow
-17.65-17.02-7.89-179.86-5.87-11.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-790949.22681.731,3921,320
Total Debt Issued
872.4790949.22681.731,3921,320
Short-Term Debt Repaid
--840.6-1,072-917.8-1,299-699
Long-Term Debt Repaid
--42.5-42.19-46.42-42.75-44.93
Total Debt Repaid
-983.1-883.1-1,114-964.22-1,342-743.93
Net Debt Issued (Repaid)
-110.7-93.1-165.05-282.4950.12575.74
Common Dividends Paid
-13.6-20.08-160.41-24.62-30.48-35.65
Other Financing Activities
-5.5--424.97129.88-197.78
Financing Cash Flow
-129.79-113.18-325.46117.86149.51342.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
116.17169.78-217.92270.99450.9797.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
245.87282.82107.39309.5300.91-245.24
Free Cash Flow Growth
73.83%163.34%-65.30%2.85%--
Free Cash Flow Margin
2.33%2.73%1.07%2.98%3.12%-2.63%
Free Cash Flow Per Share
0.420.490.180.530.52-0.42
Levered Free Cash Flow
272.38347.5-16.7366.86406.36-152
Unlevered Free Cash Flow
287.48362.810.98383.88434.13-120.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
262.37256.61305.32281.41254.71281.28
Change in Working Capital
16.216.2-198.39-74.41-42.23-603.92